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Introduction: As stress affects the brain both physiologically and chemically, researchers try to 
find novel anti-stress compounds with beneficial therapeutic effects. In this regard, the effect of 
stress and its modulation by Morin hydrate was studied using different acute models in mice.
Methods: The models employed were anoxic tolerance, swimming endurance, and acute 
restraint test. Morin hydrate or the vehicle was administered 30 minutes prior to each stress 
exposure while in the acute restraint test; the animals were pretreated for 7 days with Morin 
hydrate, vehicle, imipramine, or diazepam before stress exposure. The measured parameters were 
the onset of convulsion and immobility time in the anoxic tolerance and swimming endurance 
test, respectively, while in the acute restraint test, the animals were assessed for stress-induced 
anxiety using the elevated plus maze and depression using the forced swim test. Thereafter blood 
was withdrawn from the retro-orbital plexus and plasma separated, the brain was also isolated, 
homogenized, centrifuged, and the supernatant was obtained for biochemical estimation. 
Results: Morin hydrate (5, 10, 20 mg/kg) produced a significant reduction in immobility time 
in the swimming endurance test, while significantly increased the anoxic stress tolerance time. 
Acute restraint stress caused a significant decrease in reduced glutathione levels (which was 
reversed by Morin hydrate) and increased the level of malondialdehyde, a thiobarbituric acid 
reactive substance which is an index of oxidative stress and nitrite. These effects were attenuated 
by Morin hydrate. Also, pretreatment with Morin hydrate attenuates acute restraint stress-
associated anxiety and depression, reversed the hyperglycemia evoked by the stressful exposure 
and normalized serum cholesterol levels. 
Conclusion: These findings suggest that Morin hydrate exhibits anti-stress effects and may be 
useful in the relief of stress. 
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1. Introduction
tress is a state or feeling of being over-
whelmed by demands exceeding the personal 
and social means of coping in the prevailing 
situation (Doreddula et al., 2014). Living or-
ganisms faced with stressful situations under-
go some physiological, morphological, and biochemical 
modifications in order to survive. These modifications 
are evolved to reduce the demands and maintain the ho-
meostatic environment through a series of physiologi-
cal and/or behavioral responses (Morgan & Tromborg, 
2007; Kothiyal & Ratan, 2011), but insufficient or exces-
sive and/or extensive activation of the stress system can 
perturb the innate physiological and behavioral function 
(Tilbrook & Clarke, 2006).
Proper and effective stress management starts with 
identifying the stressor, its symptoms and effect on 
one’s health. Poor stress management contributes 
to the development of various psychiatric ailments, 
including, schizophrenia, anxiety, depression, post-
traumatic stress disorders, bipolar disorder, Alzheimer 
disease, Parkinson disease and pathologic aging (Heim 
& Nemeroff, 1999; Joshi, Sah, & Singh 2012; Marin, 
et al., 2011). A wide variety of drugs are currently 
used to reduce stress, but overdependence or misuse of 
these drugs are often associated with side effects that 
may limit their therapeutic usefulness. Adaptogens are 
herbal preparations or formulations which places an 
organism into a state of generalized elevated resistance 
to stress by promoting homeostasis (Lakshmi & Sud-
hakar, 2009). They are used in the indigenous system 
of medicine for the management of stress because they 
increase the body’s resistance to stress by normalizing 
the production of stress hormones and enhancing the 
body’s ability to cope with anxiety and fight fatigue 
without or with minimal alterations in physiological 
functions (Panossian, Wikman, & Wagner, 1999).
Flavonoids are distributed vastly in the plant kingdom 
and can be found as constituents of food products, bev-
erages and herbal preparations and have been shown to 
possess various health benefits (Catarino, Alves Silva, 
Pereira, & Cardoso, 2015; Li, Liu, Zhang, & Yu, 2008). 
Biological activities are attributable to the naturally oc-
curring flavonoids, as well as some of their synthetic 
derivatives include anti-stress (Tiwari, Mishra, Bhatt, 
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Highlights 
• Stressful life occurrences contributes to the development of anxiety and depression.
• Acute restraint stress induced hyperglycemia and enhanced generation of free radicals. 
• Morin hydrate reduces anxiety and depressive-like behaviours in mice.
• Morin hydrate normalized blood glucose, suppresses lipid peroxidation and oxidative stress in mice brain.
Plain Language Summary 
Stress is a feeling of physical, mental or emotional strain imposed by life’s situations and which affects the well-
being of individuals. Hence the need to seek therapeutic means of relieving stress in order to maintain state of mental 
and physical well-being. The study seeks to assess the effect of morin hydrate on some detrimental effects of stress. 
Morin hydrate is a natural compound gotten from the plant Morus alba. It has also been found to be a constituent of 
red wine and some fruits such as guava, almonds and figs. To evaluate Morin hydrate protective and mitigating effects 
on stress, we employed some behavioural stress paradigms such as anoxic tolerance, swimming endurance and acute 
restraint tests that can replicate stressful life events in animals. We also evaluated some biomarkers of stress (Gluta-
thione, malondialdehyde, Thiobarbituric Acid Reactive Substance, blood glucose level and serum cholesterol level) to 
further validate our claim of stress mitigating effect of morin hydrate. Having pre-treated animals with morin hydrate 
and subjecting them to different tests, we observed that stress associated behaviours such as anxiety, depression and 
fatigue were reversed and biochemical alterations triggered by stressful exposure were normalized all by morin hydrate 
treatment. These findings suggest that Morin hydrate exhibits anti-stress potentials and may be relevant for use in the 
relief of stress.
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& Chaudhary, 2015; Watanabe & Ayugase, 2008), anti-
oxidant (Zhang, et al., 2009), anti-inflammatory (Galvez 
et al., 2001), and neuroprotective compounds (Campos-
Esparza, Sánchez Gómez, & Matute, 2009).
Morin hydrate (3, 5, 7, 2’, 4’-pentahydroxyflavone) is a 
flavonoid originally isolated from the branches of Morus 
alba L (white mulberry). It is ubiquitously distributed in 
the Moraceae plants family (Manna, Aggarwal, Sethi, 
Aggarwal, & Ramesh, 2007). It is also found in fruits like 
almond, sweet chestnut, guava, and apple, and can also 
be found in red wine (Basile et al., 2000; Wijeratne et 
al., 2006; Lotito & Frei, 2006; Rattanachaikunsopon & 
Phumkhachorn, 2010). Morin hydrate possesses diverse 
pharmacological properties. These include antioxidant 
(Wu et al., 1993; 1995; Prahalathan, Kumar, & Raja, 2012; 
Merwid-Lad et al., 2012), anti-inflammatory (Galvez et 
al., 2001; Fang et al., 2003), neuroprotective (Gottlieb et 
al., 2006; Ibarretxe, Sánchez Gómez, Campos Esparza, 
Alberdi, & Matute, 2005; Zhang et al., 2010; Campos-
Esparza et al., 2009), and anticancer activity through in-
hibition of NF-кB activation (Manna et al., 2007). 
Stress is associated with the generation of free radicals, 
release of excess amount of inflammatory cytokines and 
the activation of several inflammatory genes, including 
NF- кB. In view of its antioxidant, anti-inflammatory, 
and NF-кB inhibitory properties, it is postulated that 
Morin hydrate will serve as a potent anti-stress agent.
2. Methods
2.1. Laboratory animals
Male Swiss mice (22–25 g) were used in the study. 
They were kept at 20°C–25°C with free access to wa-
ter and food and under a 12:12 h light/dark cycle. The 
animals were obtained from the central animal house, 
University of Ibadan and housed in groups in plastic 
cages. All behavioral tests were carried out between 8:00 
AM and 1:00 PM. Mice were used according to the NIH 
Guide for the Care and Use of Laboratory Animals and 
the experiments were performed after approval of the 
protocol by the Ethics Committee of the University of 
Ibadan (UI-ACUREC/App/2015/067). All efforts were 
made to minimize animal suffering and to reduce the 
number of experimental animals used.
2.2. Drugs and chemicals
Morin hydrate was purchased from Sigma-Aldrich 
(Sigma-Aldrich, USA), imipramine from Gracure phar-
maceuticals (Gracure pharmaceuticals ltd, India), and di-
azepam from Hoffman-La Roche (Hoffman-La Roche, 
Switzerland). Doses were determined on the basis of 
pilot studies and available literature. All drugs were dis-
solved in distilled water.
2.3. Experimental procedures
2.3.1. Swimming endurance test
Swimming endurance test was performed according to 
Kannur et al. (2006) method with some modifications. 
Mice were divided into four groups (n=5). Group 1 or 
the control group received 10 mL/kg of the vehicle (dis-
tilled water), and groups 2 to 4 received 5, 10, and 20 
mg/kg Morin hydrate, respectively, intraperitoneally 30 
minutes prior to the test. Each animal was then trans-
ferred to transparent tank (30×45×40 cm) containing 
water at room temperature and observed for swimming. 
The total duration of immobility was noted for 15 min-
utes. Each mouse was judged to be immobile when it 
quit struggling and remained floating motionless in the 
water, making only those movements necessary to keep 
its head above water (Subarnas et al., 1993).
2.3.2. Anoxic tolerance test
The anoxic tolerance test was carried out according to 
Kannur et al. (2006) method. Conical flasks of 250 mL 
capacity which were made air tight using rubber cork 
before the start of the experiment were used. Animals in 
this test were also divided into four groups (n=5). Group 
1 (control) received 10 mL/kg of the vehicle, groups 2 to 
4 received 5, 10, and 20 mg/kg Morin hydrate, respec-
tively intraperitoneally. Thirty minutes after treatment, 
each mouse was kept in the conical flask and the delay 
for the first convulsion was observed.
2.3.3. Acute restraint test
Acute restraint stress model was carried out accord-
ing to the method of Masood et al. (2003) with minor 
modifications. The animals were allotted into six groups 
(n=6). Group 1 (non-stressed) received 10 mL/kg vehi-
cle, group 2 (control) also received the vehicle, groups 
3 to 5 received 5, 10, and 20 mg/kg Morin hydrate re-
spectively while group 6 (positive control) were further 
divided into two subgroups. Subgroup A received 1 mg/
kg diazepam and subgroup B received 12 mg/kg, imip-
ramine. All treatments were carried out intraperitone-
ally for 7 days with the test compound or vehicle or the 
reference drug and on the seventh day, 30 minutes after 
the last dose, the animals in groups 2 to 6 were exposed 
to stress by restraining them in a plastic restrainer (a 50 
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mL cylindrical tube with holes for air circulation) for 2 
hours. At the end of the procedure, all animals were sub-
jected to forced swim test and elevated plus maze test in 
order to assess for depression and anxiety-like behavior, 
respectively. Following behavioral test, the animals were 
anesthetized and blood was withdrawn from the retro or-
bital plexus for the estimation of total glucose, protein, 
cholesterol and triglyceride levels. The animals were 
then sacrificed through cervical dislocation and the brain 
was excised for the estimation of antioxidant parameters. 
2.3.4. The elevated plus maze
The elevated plus maze is a validated behavioral assay 
for assessing anxiolytic and anxiogenic-like activities of 
pharmacological agents in rodents (Walf & Frye, 2007). 
The apparatus is made of wood consisting of two open 
arms (30×5×0.25 cm) which are essentially unprotected 
boards and two closed arms (30×5×15 cm) which are bor-
dered by walls emanating from a common central plat-
form (5×5 cm) and elevated to a height of 50 cm above 
the floor level. Each mouse was placed onto the middle of 
the apparatus facing an open arm. The time spent in each 
arm and the number of entries into each arm was manu-
ally recorded by a blind observer for 5 minutes. At the end 
of each trial, the apparatus was wiped clean with 70% eth-
anol solution and dried in order to prevent olfactory cue. 
An entry was defined as when all four paws have crossed 
the line between the arm and the central area. Anxiolytic 
action was defined by increased time in and or number of 
entries to open arms (Walf & Frye, 2007). 
2.3.5. Forced swim test
Forced swim test was carried out according to Deepika 
et al. (2013) method with minor alterations. Briefly, mice 
were individually forced to swim in a transparent Plexi-
glas cylinder of dimension (37×37×30 cm) filled with 
water to a depth of 25 cm at 25°C. The total duration 
of immobility was noted during a 6 min test session by 
a blind observer. Each mouse is considered immobile 
when it ceased struggling and floats passively in wa-
ter, only making movements necessary to keep its head 
above the water.
2.3.6. Measurement of blood glucose
Blood glucose level was measured using a blood glu-
cose monitoring meter (AccuCheck performer meter) and 
blood glucose strip (AccuCheck). The strip was placed 
into the meter and blood was dropped at the tip of it and 
drawn up into the meter. Immediately the blood glucose 
reading was displayed on the meter and recorded. 
2.3.7. Determination of serum total cholesterol
Serum cholesterol level was determined by enzymat-
ic colorimetric method using the assay kit (Spinreact, 
Spain) according to the manufacturer’s protocol follow-
ing the method earlier described (Young & Friedman, 
2001). Briefly, the reagent (containing the enzymes cho-
lesterol esterase, cholesterol oxidase, peroxidase, and 
4-aminophenazone) was dissolved with the buffer to 
give the working reagent. The mixture was gently mixed 
to dissolve the contents. About 1.0 mL of the working 
reagent was mixed with 10 µL of serum or cholesterol 
standard (200 mg/dL) and the mixture was incubated for 
10 minutes at room temperature. Afterwards, the absor-
bance (A) of the samples and standard is read against the 
blank at 500 nm. The concentration of cholesterol in the 
sample was obtained from the following equation:
mg/dL Cholesterol 
in the Sample×200(Standard Conc.)=
(A) Sample–(A) Blank
(A) Standard–(A) Blank
2.3.8. Determination of serum triglyceride levels
Serum triglyceride level was determined by enzymat-
ic colorimetric method using the assay kit (Spinreact, 
Spain) according to the manufacturer’s protocol fol-
lowing the method earlier described (Bucolo & David, 
1973). About 1 mL of the reagent is mixed with 10 µL 
of the sample or standard and the mixture incubated for 
5 minutes at 37oC. Absorbance (A) is read at 500 nm. 
Concentration (mg/dL) of triglyceride in the sample is 
obtained from the equation:
(A) Sample / (A) Standard×200 (Standard Conc.)
2.3.9. Protein estimation
Protein estimation was carried out according to the 
method of Gornall et al. (1949). Briefly, 0.1 mL of sam-
ple is added to 0.9 mL of distilled water in a test tube, 3 
mL of biuret reagent was added and the mixture incubat-
ed at room temperature for 30 min and absorbance was 
read at 540 nm. The standard (1 mg/mL bovine serum 
albumin) was measured in the range of 0.01-0.1 mg/mL.
2.3.10. Determination of glutathione (GSH) 
concentration 
Brain GSH concentration was determined using the 
method of Moron et al. (1979). Briefly, 0.1 mL of brain 
supernatant was added to test tubes containing 0.9 mL 
sodium phosphate buffer (0.2 M, pH 8.0). About 1 mL 
of 20% TCA containing 1mM EDTA was added and 
the mixture was allowed to stand for 5 min, and after-
wards centrifuged at 10000 rpm for 10 min. Around 
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0.25 mL of the supernatant obtained was added to 
fresh test tubes containing 0.75 mL of phosphate buf-
fer, and 2 mL of 0.6 mM DTNB was added. The mix-
ture was allowed to stand for 5–10 min and absorbance 
was read at 412 nm. A standard curve of reduced glu-
tathione was used to calculate GSH levels, which were 
expressed as μmol/g tissue.
2.3.11. Determination of malondialdehyde in 
brain tissues
Determination of malondialdehyde (MDA), a bio-
marker of lipid peroxidation in brain tissue homogenate 
was carried out according to the method earlier described 
(Adam-Vizi and Seregi, (1982) in which MDA, an end-
product of lipid peroxidation, reacts with Thiobarbituric 
Acid (TBA) to form a colored complex. Briefly, an ali-
quot of 0.1 mL of brain supernatant was added to plain 
tubes containing 1.9 mL of Tris–KCl buffer. About 0.5 
mL of 30% TCA and 0.5 mL of 0.75% TBA were added 
to the mixture and incubated in a water bath at 96°C for 
60 min. The mixture was then cooled under running wa-
ter, then 2 mL of butanol was added and centrifuged at 
3000 rpm for 10 min. After centrifugation, the reaction 
product was determined at 532 nm using MDA as stan-
dard. MDA values were expressed as µmol/g tissue.
2.3.12. Estimation of brain nitrite level
Brain nitrite concentration was estimated using Greiss 
reagent, which serves as an indicator of nitric oxide pro-
duction. About 300 µL of brain supernatant was added to 
test tube containing 100 µL Greiss reagent (1:1 solution 
of 1% sulfanilamide in 5% phosphoric acid and 0.1% of 
N-(1-Naphthyl) ethylenediamine dihydrochloride. Then, 
2.6 mL of distilled water was added to the mixture and 
incubated at room temperature for 30 min. The blank 
was also prepared by adding 2.9 mL of distilled water to 
0.1 mL Griess reagent and absorbance was read at 548 
nm (Green et al., 1982). The brain nitrite concentration 
was estimated from a standard curve obtained from so-
dium nitrite (0-100 uM).
2.4. Statistical analysis
The results are expressed as Mean±S.E.M. The statistical 
significance was determined by 1-way ANOVA followed 
by Tukey post hoc test. Graph Pad Prism software version 
4.03 was used for statistical analysis. P value of less than 
0.05 was considered to be statistically significant.
3. Results
3.1. Effect of morin hydrate on immobility time in 
the swimming endurance test
Figure 1 presents the effect of Morin hydrate on im-
mobility time in the swimming endurance test. One-way 
ANOVA revealed a significant difference among treat-
ment groups (F
3,16
=17.10, P<0.0001). Post hoc compari-
sons indicated that doses 10 and 20 mg/kg increase swim-
ming endurance by reducing immobility time compared 
to VEH group (Tukey post hoc comparisons, P<0.01).
3.2. Effect of morin hydrate on anoxic stress tolerance
The effect of Morin hydrate on the onset of convulsion 
in mice subjected to anoxia is shown in Figure 2. One-
way ANOVA revealed a significant difference among 
treatment groups (F
3,16
=15.20, P<0.0001). Post hoc 
10 
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Figure 1: Effect of Morin hydrate on the immobility time in the swimming endurance test. 
Each bar is expressed as Mean ± SEM, (n = 5 per group).  
*P < 0.01 when compared to control group (ANOVA followed by Tukey post-hoc test). 
Abbreviations; VEH: Vehicle, MH: Morin hydrate 
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Figure 1. Effect of morin hydrate on the immobility time in the swimming endurance test
Each bar is expressed as Mean ± SEM, (n=5 per group). * P<0.01 When compared to control group (ANOVA followed by Tukey 
post-hoc test); VEH: Vehicle; MH: Morin Hydrate
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comparisons indicated that all doses were effective in in-
creasing anoxic tolerance compared to VEH (Tukey post 
hoc comparisons, P<0.001).
3.3. Effect of morin hydrate on the duration of im-
mobility in the forced swim test
The effect of Morin hydrate on stress-induced depres-
sive-like behavior as measured by the duration of im-
mobility in the forced swim test is shown in Figure 3. 
One-way ANOVA revealed a significant difference in 
immobility time among treatment groups (F
5,12
=6.952; 
P<0.0029). Acute restraint stress caused a significant in-
crease in the duration of immobility in the VEH acute 
stress group when compared to VEH non-stress group 
(Tukey post hoc comparison, P<0.001) (Figure 3). The 
reference drug, imipramine significantly reversed immo-
bility as did all the doses of MH (each group compared 
to the vehicle acute stress group) (Tukey post hoc com-
parison, P<0.001).
3.4. Effect of morin hydrate on the elevated plus maze
The effect of Morin hydrate on stress-induced anxi-
ety-like behavior as measured by the time spent in the 
open arms is shown in Figure 4. One-way ANOVA re-
vealed a significant difference among treatment groups 
(F
5,12
=69.51; P<0.0001). The VEH acute stress group 
spent significantly less time in the open arm compared 
to the VEH non-stress group. Diazepam significantly re-
versed this effect as well as Morin hydrate at all doses, 
and even made the mice less anxious than the vehicle 
non- stress mice (Tukey post hoc comparison, P<0.001). 
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Figure 3. Effect of morin hydrate on the duration of immobility in the FST after acute restraint stress
Each bar represents the Mean ± S.E.M; # P<0.001 When compared to control group; * P<0.001 When compared to the untreated 
group (ANOVA followed by Tukey post-hoc test); VEH N-S: Vehicle Non-Stress; VEH A-S: Vehicle Acute Stress; IMI: Imipra-
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Figure 2. Effect of morin hydrate on anoxic stress tolerance
Each bar represents the mean±SEM, (n=5 per group); * P<0.001 When compared to control group (ANOVA followed by Tukey 
post-hoc test); VEH: Vehicle; MH: Morin Hydrate
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3.5. Effect of morin hydrate on acute restraint 
stress-induced changes in biochemical parameters
Acute restraint stress raises serum glucose level (Fig-
ure 5). One-way ANOVA revealed an overall difference 
among treatment groups (F
5,12
=12.71, P<0.0001). A sig-
nificant increase in serum glucose level in VEH acute 
stress group was observed compared to non-stress group 
(Tukey post hoc comparisons, P<0.05). Mori hydrate at 
all doses significantly (P<0.05) reversed this effect. Fur-
thermore, 1-way ANOVA indicated that acute restraint 
stress significantly decreased cholesterol (F
4,10
=7.433, 
P=0.0048) and triglyceride (F
4,10
=24.64, P<0.0001) lev-
els compared to VEH non-stress group. Morin hydrate 
(at doses 5 and 10 mg/kg) significantly reversed this ef-
fect on cholesterol levels, while no significant effect was 
observed on triglyceride and protein levels (Tukey post 
hoc comparisons, P<0.05).
3.6. Effect of morin hydrate on oxidative mea-
surements
One-way ANOVA revealed a significant difference in 
the levels of brain GSH (F
4,10
=8.166, P=0.0034), MDA 
(F
4,10
, P<0.0001), and nitrite (F
4,10
, P=0.0002) among 
treatment groups. Acute restraint stress produced a sig-
nificant reduction in brain GSH levels in the VEH acute 
stress group compared to the VEH non-stress group as 
shown in Figure 6. Morin hydrate at all doses significant-
ly reversed the reduction in GSH levels (Tukey post hoc 
comparison, P<0.05). Furthermore, acute restraint stress 
caused a significant increase in brain MDA and nitrite 
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levels in the VEH acute stress group when compared 
to VEH non-stress group (Tukey post hoc comparison, 
P<0.001 and P<0.01 respectively) as shown in Figures 
7 and 8, respectively. All doses of Morin hydrate signifi-
cantly reversed this effect (each group compared to the 
VEH acute stress group).
4. Discussion
The physiological changes induced by stress under nor-
mal circumstances are usually self-limiting and adaptive, 
but when the stressful event overrides its ‘threshold’ lim-
its, it becomes irreversible, resulting in the pathogenesis 
of several disorders. The basic trigger for these disorders 
is the exhaustion of energy supply and breakdown of en-
ergy metabolism following circulatory glucose depriva-
tion (Singh & Yadav, 2014). In the desire to enhance the 
coping mechanism, the science of adaptation focuses on 
expounding mechanisms that may help counteract exag-
gerated and unnecessary responses to stress (Rai et al., 
2003). These adaptogens normalize and strengthen body 
systems and functions that have been compromised by 
stress, and provide protective effects against a wide vari-
ety of stressors. In general, they enhance the organism’s 
ability to adapt and evade damages incurred from stress-
ful exposure (Panossian et al., 1999). 
The swimming endurance paradigm is the most widely 
used model for evaluating the adaptogenic property of a 
novel compound (Anisman & Zacharko, 1991; Subarnas 
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et al., 1993). This model is based on the observation that 
rodents, when forced to swim in a restricted space, be-
come immobile after an initial period of vigorous activ-
ity signifying stress (Umukoro and Aladeokin, 2010). In 
the swimming endurance model conducted, a significant 
reduction in immobility time was observed at all doses 
administered. This increase endurance could be due to 
normalization of blood catecholamine and monoamine 
oxidase levels, a decline in muscle glycogenolysis, or a 
decrease in muscle concentrations of two toxic by-prod-
ucts of muscular efforts; lactic acid and ammonia (Deb-
nath et al., 2011). It may also be attributed to increase in 
the utilization of the Adenosine Triphosphate (ATP) path-
way or the anti-oxidant effect of Morin hydrate which 
prevents free radical-induced damage to vital organs.
Oxygen is a vital element on which all body functions 
including cellular respiration are dependent. Anoxic stress 
tolerance is characterized by shortage of oxygen supply 
which depicts an environmental stressor and any drug 
which increases adaptation under anoxic condition by in-
creasing tolerance can act as an adaptogenic agent (Singh 
& Yadav, 2014). The significant increase in anoxic toler-
ance time could imply either resilience to anoxia or reduc-
tion in cerebral oxygen consumption, effects that are very 
beneficial in protecting neuronal cells against oxidative 
damage. In this study, Morin hydrate produced a dose-de-
pendent increase in anoxic stress tolerance time, indicat-
ing its anti-stress activity. This observed prolongation of 
mean convulsion time could be caused by the antioxidant 
and free radical scavenging activity of Morin hydrate. 
Restraint is one of the best explored models of stress in 
mice. This paradigm which restricts mobility and triggers 
aggression is a model of physical and emotional stress, 
and could trigger some psychiatric disorders such as anx-
iety and depression (Kulkarni & Juvekar, 2008). Anxiety 
and depression are the most prevalent psychiatric diag-
nosis in patients visiting psychiatric clinics (Gautam et 
al., 2012). Based on evidence, association between mark-
ers of stress and these psychological disorders has been 
amassed. The elevated plus maze is a validated model 
widely used for assessing anxiety-like behavior and elu-
cidating mechanisms underlying anxiety-like behavior 
in rodents. The test is based on the natural avoidance of 
mice for open and elevated spaces, as well as on their 
natural spontaneous exploratory behavior in novel envi-
ronments (Rodgers & Cole, 1993). The paradigm uses an 
elevated, plus-shaped apparatus with two open and two 
closed arms. Anxiety is expressed by a rodent spending 
more time in the enclosed arms compared to the open 
arms. Anxiolytic drugs have the characteristics of reduc-
ing anxiety reactions of rodents in elevated plus maze 
test. Animals treated with an anxiolytic tend to explore 
and spend more time in the open arm as compared with 
their untreated counterparts. The current study indicated 
that restraint stress caused a reduction in the time spent in 
the open arms which was reversed by treatment with Mo-
rin hydrate, suggesting that it could reduce fear and anxi-
ety experienced after exposure to stressful conditions.
The FST model, like the swimming endurance test 
is based on fear or helplessness behavior in response 
to some inescapable and confined space and is sensi-
tive to various antidepressant drugs. The alteration 
observed in the acute stress-induced immobility in the 
FST suggests that Morin hydrate attenuates stress-in-
duced depressive-like behavior.
 
0
15
30
45
60
75
90
VEH N-S VEH A-S MH5 MH10 MH20
Ni
tr
ite
 (µ
gm
ol
/m
g 
pr
ot
ei
n)
#
**
*
**
mg/kg
Acute restraint stress
Figure 8. Effect of morin hydrate on nitrite levels in mice brain exposed to acute restraint stress
Each bar is expressed as Mean±S.E.M; # P<0.01 when compared with the control; *P<0.01; ** P<0.001 when compared with the 
stressed control group (one-way ANOVA followed by Tukey post-hoc test); VEH N-S: Vehicle Non-Stress; VEH A-S: Vehicle 
Acute Stress; MH: Morin Hydrate
Toyin Olonode, E., et al. (2018). Morin Hydrate, Acute Stress-Induced Behavioral, and Biochemical Alterations. BCN, 9(2), 195-208.
Basic and Clinical
204
May, June 2018, Volume 9, Number 3
Increase in glucose concentrations in mice subjected to 
restraint stress has been previously reported (Sugimoto 
et al., 1998), and the result of this study agrees with the 
report. Stress-induced activation of the sympathetic ner-
vous system stimulates the cells of the adrenal medulla 
to release adrenaline. Adrenaline has been reported to 
possess hyperglycemic effect as a result of its ability to 
suppress insulin secretion from the β-cells of the pancre-
as, resulting in elevated blood glucose (Shimazu, 1981; 
Kioukia-Fougia, 2002). Furthermore, adrenaline could 
stimulate adenylyl cyclase in the adipose tissue and 
muscle, resulting in an elevation in intracellular level of 
cAMP, whose role is to facilitate the mobilization of glu-
cose and fatty acid reserves in tissues. Increase in cAMP 
levels results in a net increase in hepatic glucose pro-
duction by stimulation of phosphorylase activation, sup-
pression of glycogen synthetase activity, and stimulation 
of gluconeogenesis (Sutherland & Rodriguez, 1989). 
The significant elevation of blood glucose may also be 
as result of restraint stress-induced secretion of corticos-
terone from the adrenal glands as corticosterone has 
been reported to induce hyperglycemia and cause insulin 
resistance independent of glucose transport (Nicolson, 
1997; Wass et al., 1996; Tappy et al., 1994). In this study, 
Morin hydrate was found to reverse the hyperglycemic 
effect observed after acute restraint.
Changes in the levels of particular lipids in response to 
stress have been recognized but the patterns and types of 
stress causing these changes have not been consistent. 
Stress-induced corticosterone release reduces the levels 
of triglycerides and cholesterol. This is due to the con-
version of stored glycogen into glucose and utilization 
of fat reserves as alternative source of energy during 
stressful conditions (Kioukia Fougia, 2002). This reduc-
tion in serum triglyceride could also be as a result of the 
action of hormone-sensitive lipase which is triggered by 
adrenaline to mobilize fatty acids from adipose tissue tri-
glycerides. In this study, restraint stress reduced serum 
cholesterol and triglyceride levels, while treatment with 
Morin hydrate normalized the cholesterol level but with 
no effect on triglycerides. This is probably due to diver-
sion of energy substrates to the specific stress demanding 
sites (Singh et al., 2001).
Stress has been well documented to enhance the pro-
duction of free radicals (Liu et al., 1994). Increase free 
radicals has been linked to hyper-activation of the hy-
pothalamic-pituitary-adrenal axis with resultant increase 
in corticosterone secretion (Liu et al., 1996). Several 
reports suggested the critical role of stress-induced free 
radicals in several biochemical imbalances and their as-
sociated pathological outcomes (Olivenza, 2000). The 
analysis of lipid peroxidation revealed the occurrence 
of oxidative damage since an increased level of MDA 
was observed in the brain of stressed mice. The brain is 
largely sensitive to peroxidase damage due to its high 
oxygen tension, low antioxidant capacity and rich supply 
of oxidizable substrates (Metodiewa & Koska, 1999). 
Lipid peroxidation enhances depletion of intracellular 
endogenous antioxidant; glutathione, which serves as 
a first line of defense against oxidative assault. Morin 
hydrate at all administered doses reduced lipid per-
oxidation, lowered nitric oxide levels, and reversed the 
restraint stress-induced depletion in brain glutathione 
content. This further demonstrates the stress-relieving 
potential of Morin hydrate. 
In conclusion, Morin hydrate increased resistance in 
the swimming endurance test and protects against an-
oxic stress. Furthermore, Morin hydrate protects against 
stress induced anxiety and depressive-like behavior, re-
duces hyperglycemia, and normalizes blood lipid levels. 
Finally, it protects against oxidative stress.
Ethical Considerations
Compliance with ethical guideline 
Mice were used according to the NIH Guide for the Care 
and Use of Laboratory Animals and the experiments 
were performed after approval of the protocol by the 
Ethics Committee of the University of Ibadan (UI-ACU-
REC/App/2015/067). All efforts were made to minimize 
animal suffering and to reduce the number of experimen-
tal animals used. 
Funding
The authors acknowledge the Neuropharmacol-
ogy Laboratory of the Department of Pharmacology 
and Therapeutics, College of Medicine, University of 
Ibadan, Nigeria for providing technical support, and the 
assistance of the IBRO writing workshop 2017 for creat-
ing a platform for editing this manuscript. The study was 
extracted from the PhD thesis of the first author.
Conflict of interest
The authors declared no conflict of interest.
Toyin Olonode, E., et al. (2018). Morin Hydrate, Acute Stress-Induced Behavioral, and Biochemical Alterations. BCN, 9(2), 195-208.
Basic and Clinical
205
May, June 2018, Volume 9, Number 3
References
Ádám Vizi, V., & Seregi, A. (1982). Receptor independent 
stimulatory effect of noradrenaline on Na,K-ATPase in rat 
brain homogenate. Bio-chemical Pharmacology, 31(13), 2231–6. 
[DOI:10.1016/0006-2952(82)90106-X]
Anisman, H., Zacharko, R. M. 1991. Multiple neurochemical 
and behavioural consequences of stressors: Implications for 
depression. In: S. E. File (Ed.), Psychopharmacology of anxiolyt-
ics and antidepressants (pp. 57-82). New York: Pergamon Press. 
[DOI:10.1016/B978-0-08-040698-5.50008-9]
Basile, A., Sorbo, S., Giordano, S., Ricciardi, L., Ferrara, S., Mon-
tesano, D., et al., (2000). Antibacterial and allelopathic activity 
of extract from Castanea sativa leaves. Fitoterapia, 71, S110–6. 
[DOI:10.1016/S0367-326X(00)00185-4]
Bucolo, G., & David, H. (1973). Quantitative determination of 
serum triglycerides by the use of enzymes. Clinical Chemistry, 
19(5), 476-82. PMID: 4703655 [PMID]
Campos Esparza, M. R., Sánchez Gómez, M. V., & Matute, C. 
(2009). Molecular mechanisms of neuroprotection by two 
natural antioxidant polyphenols. Cell Calcium, 45(4), 358–68. 
[DOI:10.1016/j.ceca.2008.12.007]
Catarino, M., Alves Silva, J., Pereira, O., & Cardoso, S. (2015). 
Antioxidant capacities of flavones and benefits in oxidative-
stress related diseases. Current Topics in Medicinal Chemistry, 
15(2), 105–19. [DOI:10.2174/1568026615666141209144506]
Debnath, J., Prakash, T., Karki, R., Kotresha, D., & Sharma, P. 
(2011). An experimental evaluation of anti-stress effects of 
Terminalia chebu-la. Journal of Physiological and Biomedical Sci-
ences, 24(2), 13-19.
Deepika, R., Hemamalini, K., & Vasireddy, U. (2013). Adapto-
genic activity of methanolic extract of anogeissus latifolia wall 
and tabebuia rosea (Bertol.) DC on different experimental 
models. International Journal of Pharmacy and Pharmaceutical 
Sciences, 5(4), 457-63.
Doreddula, S. K., Bonam, S. R., Gaddam, D. P., Desu, B. S. R., 
Ramarao, N., & Pandy, V. (2014). Phytochemical analysis, 
antioxidant, an-tistress, and nootropic activities of aqueous 
and methanolic seed extracts of ladies finger (Abelmoschus 
esculentus L.) in mice. The Scientific World Journal, 2014, 1–14. 
[DOI:10.1155/2014/519848]
Fang, S. H., Hou, Y. C., Chang, W. C., Hsiu, S. L., Lee Chao, P. 
D., & Chiang, B. L. (2003). Morin sulfates/glucuronides exert 
anti-inflammatory activity on activated macrophages and 
decreased the incidence of septic shock. Life Sciences, 74(6), 
743–56. [DOI:10.1016/j.lfs.2003.07.017]
Galvez, J., Coelho, G., Crespo, M. E., Cruz, T., Rodriguez-Ca-
bezas, M. E., Concha, A., et al., (2001). Intestinal anti-inflam-
matory activity of morin on chronic experimental colitis in the 
rat. Alimentary Pharmacology and Therapeutics, 15(12), 2027–39. 
[DOI:10.1046/j.1365-2036.2001.01133.x]
Gautam, M., Agrawal, M., Gautam, M., Sharma, P., Gautam, A., 
& Gautam, S. (2012). Role of antioxidants in generalised anxi-
ety disorder and depression. Indian Journal of Psychiatry, 54(3), 
244. [DOI:10.4103/0019-5545.102424]
Gornall, A. G., Bardawill, C. J., & David, M. M. (1949). Deter-
mination of serum proteins by means of the biuret reaction. 
Journal of Biological Chemistry, 177(2), 751-66. [PMID]
Gottlieb, M., Leal Campanario, R., Campos Esparza, M. R., 
Sánchez Gómez, M. V., Alberdi, E., Arranz, A., et al., (2006). 
Neuropro-tection by two polyphenols following excitotoxic-
ity and experimental ischemia. Neurobiology of Disease, 23(2), 
374–86. [DOI:10.1016/j.nbd.2006.03.017]
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wish-
nok, J. S., & Tannenbaum, S. R. (1982). Analysis of nitrate, ni-
trite, and [15N] nitrate in biological fluids. Analytical Biochem-
istry, 126(1), 131–8. [DOI:10.1016/0003-2697(82)90118-X]
Heim, C., & Nemeroff, C. B. (1999). The impact of early adverse 
experiences on brain systems involved in the pathophysiol-
ogy of anxiety and affective disorders. Biological Psychiatry, 
46(11), 1509–22. [DOI:10.1016/S0006-3223(99)00224-3]
Ibarretxe, G., Sánchez Gómez, M. V., Campos Esparza, M. R., 
Alberdi, E., & Matute, C. (2005). Differential oxidative stress 
in oligodendro-cytes and neurons after excitotoxic insults 
and protection by natural polyphenols. Glia, 53(2), 201–11. 
[DOI:10.1002/glia.20267]
Joshi, T., Sah, S. P., & Singh, A. (2012). Antistress activity of 
ethanolic extract of Asparagus racemosus Willd roots in mice. 
Indian Journal of Experimental Biology, 50(6), 419–24. PMID: 
22734253 [PMID]
Kannur, D. M., Hukkeri, V. I., & Akki, K. S. (2006). Adapto-
genic activity of Caesalpinia bonduc seed extracts in rats. 
Journal of Ethnophar-macology, 108(3), 327–31. doi: 10.1016/j.
jep.2006.05.013 [DOI:10.1016/j.jep.2006.05.013]
Kioukia-Fougia, N. (2002). The effects of stress exposure on the 
hypothalamic–pituitary–adrenal axis, thymus, thyroid hor-
mones and glucose levels. Progress in Neuro-Psychopharmacolo-
gy and Biological Psychiatry, 26(5), 823–30. [DOI:10.1016/S0278-
5846(01)00297-4]
Kioukia Fougia, N. (2002). The effects of stress exposure on the 
hypothalamic–pituitary–adrenal axis, thymus, thyroid hor-
mones and glucose levels. Progress in Neuro-Psychopharmacolo-
gy and Biological Psychiatry, 26(5), 823–30. [DOI:10.1016/S0278-
5846(01)00297-4]
Kothiyal, P., & Ratan, P. (2011). Antistress effect of fagopyrum 
esculentum in rats subjected to forced swimming endurance 
test. Pharma-Cologyonline, 3, 290-6.
Kulkarni, M., & Juvekar, A. (2008). Attenuation of acute and 
chronic restraint stress-induced perturbations in experimen-
tal animals by Ne-lumbo nucifera Gaertn. Indian Journal of 
Pharmaceutical Sciences, 70(3), 327-32. [DOI:10.4103/0250-
474X.42982]
Lakshmi, B. V. S., & Sudhakar, M. (2009). Screening of Psidium 
guajava leaf extracts for antistress activity in different experi-
mental animal models. Pharmacognosy Research, 1(6), 359-66.
Li, N., Liu, J. H., Zhang, J., & Yu, B. Y. (2008). Comparative 
evaluation of cytotoxicity and antioxidative activity of 20 
flavonoids. Journal of Agricultural and Food Chemistry, 56(10), 
3876–83. [DOI:10.1021/jf073520n]
Liu, J., Wang, X., & Mori, A. (1994). Immobilization stress-
induced antioxidant defense changes in rat plasma: Effect of 
treatment with re-duced glutathione. International Journal of Bi-
ochemistry, 26(4), 511–7. [DOI:10.1016/0020-711X(94)90008-6]
Liu, J., Wang, X., Shigenaga, M. K., Yeo, H. C., Mori, A., & Ames, 
B. N. (1996). Immobilization stress causes oxidative damage to 
Toyin Olonode, E., et al. (2018). Morin Hydrate, Acute Stress-Induced Behavioral, and Biochemical Alterations. BCN, 9(2), 195-208.
Basic and Clinical
206
May, June 2018, Volume 9, Number 3
lipid, pro-tein, and DNA in the brain of rats. The FASEB Jour-
nal, 10(13), 1532–8. [DOI:10.1096/fasebj.10.13.8940299]
Lotito, S., & Frei, B. (2006). Consumption of flavonoid-rich 
foods and increased plasma antioxidant capacity in humans: 
Cause, conse-quence, or epiphenomenon. Free Radical Biol-
ogy and Medicine, 41(12), 1727–46. [DOI:10.1016/j.freeradbi-
omed.2006.04.033]
Manna, S. K., Aggarwal, R. S., Sethi, G., Aggarwal, B. B., & 
Ramesh, G. T. (2007). Morin (3, 5, 7, 2′, 4′-pentahydroxy-
flavone) abolishes nuclear factor-κB activation induced by 
various carcinogens and inflammatory stimuli, leading to 
suppression of nuclear factor-κB–regulated gene expression 
and up-regulation of apoptosis. Clinical Cancer Research, 13(7), 
2290-7. [DOI:10.1158/1078-0432.CCR-06-2394]
Marin, M. F., Lord, C., Andrews, J., Juster, R. P., Sindi, S., Ar-
senault Lapierre, G., et al., (2011). Chronic stress, cognitive 
function-ing and mental health. Neurobiology of Learning and 
Memory, 96(4), 583–95. [DOI:10.1016/j.nlm.2011.02.016]
Masood, A., Banerjee, B., Vijayan, V. ., & Ray, A. (2003). Modula-
tion of stress-induced neurobehavioral changes by nitric ox-
ide in rats. European Journal of Pharmacology, 458(1-2), 135–9. 
[DOI:10.1016/S0014-2999(02)02688-2]
Merwid Ląd, A., Trocha, M., Chlebda, E., Sozański, T., Mag-
dalan, J., Ksiądzyna, D., et al., (2012). Effects of morin-5′-
sulfonic acid sodium salt (NaMSA) on cyclophosphamide-
induced changes in oxido-redox state in rat liver and 
kidney. Human & Experimental Toxi-cology, 31(8), 812–9. 
[DOI:10.1177/0960327111431090]
Metodiewa, D., & Kośka, C. (1999). Reactive oxygen species 
and reactive nitrogen species: Relevance to cyto(neuro)toxic 
events and neuro-logic disorders: An overview. Neurotoxicity 
Research, 1(3), 197–233. [DOI:10.1007/bf03033290]
Morgan, K. N., & Tromborg, C. T. (2007). Sources of stress in 
captivity. Applied Animal Behaviour Science, 102(3-4), 262–302. 
[DOI:10.1007/BF03033290]
Moron, M. S., Depierre, J.W., & Mannervik, B. (1979). Levels of 
glutathione, glutathione reductase and glutathione S-trans-
ferase activities in rat lung and liver. Biochimica et Biophysica 
Acta (BBA) - General Subjects, 582(1), 67–78. [DOI:10.1016/0304-
4165(79)90289-7]
Nicolson, S. C. (1997). Glucose: Enough versus too much. Jour-
nal of Cardiothoracic and Vascular Anesthesia, 11(4), 409–10. 
[DOI:10.1016/S1053-0770(97)90045-8]
Olivenza, R., Moro, M. A., Lizasoain, I., Lorenzo, P., Fernández, 
A. P., Rodrigo, J., et al., (2001). Chronic stress induces the ex-
pression of inducible nitric oxide synthase in rat brain cortex. 
Journal of Neurochemistry, 74(2), 785–91. [DOI:10.1046/j.1471-
4159.2000.740785.x]
Panossian, A., Wikman, G., & Wagner, H. (1999). Plant adapto-
gens III. Earlier and more recent aspects and concepts on their 
mode of action. Phytomedicine, 6(4), 287–300. [DOI:10.1016/
S0944-7113(99)80023-3]
Prahalathan, P., Kumar, S., & Raja, B. (2012). Morin attenuates 
blood pressure and oxidative stress in deoxycorticosterone 
acetate-salt hypertensive rats: A biochemical and histopatho-
logical evaluation. Metabolism, 61(8), 1087–99. [DOI:10.1016/j.
metabol.2011.12.012]
Rai, D., Bhatia, G., Palit, G., Pal, R., Singh, S., & Singh, H. K. (2003). 
Adaptogenic effect of Bacopa monniera (Brahmi). Pharmacol-
ogy Biochemistry and Behavior, 75(4), 823–30. [DOI:10.1016/
S0091-3057(03)00156-4]
Rattanachaikunsopon, P., & Phumkhachorn, P. (2010). Contents 
and antibacterial activity of flavonoids extracted from leaves 
of Psidium guajava. Journal of Medicinal Plants Research, 4(5), 
393-396.
Rodgers, R. J., & Cole, J. C. (1993). Anxiety enhancement in 
the murine elevated plus maze by immediate prior expo-
sure to social stressors. Physiology & Behavior, 53(2), 383–8. 
[DOI:10.1016/0031-9384(93)90222-2]
Shimazu, T. (1981). Central nervous system regulation of liver 
and adipose tissue metabolism. Diabetologia, 20(S1), 343–56. 
[DOI:10.1007/BF00254502]
Singh, B., Saxena, A. K., Chandan, B. K., Gupta, D. K., Bhu-
tani, K. K., & Anand, K. K. (2001). Adaptogenic activity of a 
novel, withanolide-free aqueous fraction from the roots of-
Withania somnifera Dun. Phytotherapy Research, 15(4), 311–8. 
[DOI:10.1002/ptr.858]
Singh, S., & Yadav, A. K. (2014). Protection of stress induced be-
havioural and physiological alteration by marsilea quadrifolia 
in rodents. Journal of Chemical and Pharmaceutical Research, 6(7), 
2207-17.
Subarnas, A., Tadano, T., Nakahata, N., Arai, Y., Kinemuchi, H., 
Oshima, Y., et al., (1993). A possible mechanism of antidepre-
sant activity of beta-amyrin palmitate isolated from lobelia 
inflata leaves in the forced swimming test. Life Sciences, 52(3), 
289–96. [DOI:10.1016/0024-3205(93)90220-W]
Sugimoto, Y., Yamada, J., & Noma, T. (1998). Effects of anxio-
lytics, diazepam and tandospirone, on immobilization stress-
induced hyper-glycemia in mice. Life Sciences, 63(14), 1221–6. 
[DOI:10.1016/S0024-3205(98)00384-1]
Sutherland, R. J., & Rodriguez, A. J. (1989). The role of the for-
nix/fimbria and some related subcortical structures in place 
learning and memory. Behavioural Brain Research, 32(3), 265–
77. [DOI:10.1016/S0166-4328(89)80059-2]
Tappy, L., Randin, D., Vollenweider, P., Vollenweider, L., 
Paquot, N., Scherrer, U., et al., (1994). Mechanisms of dexa-
methasone-induced insulin resistance in healthy humans. The 
Journal of Clinical Endocrinology & Metabolism, 79(4), 1063–9. 
[DOI:10.1210/jcem.79.4.7962275]
Tilbrook, A. J., & Clarke, I. J. (2006). Neuroendocrine mechanisms 
of innate states of attenuated responsiveness of the hypothala-
mo-pituitary adrenal axis to stress. Frontiers in Neuroendocri-
nology, 27(3), 285–307. [DOI:10.1016/j.yfrne.2006.06.002]
Tiwari, N., Mishra, A., Bhatt, G., & Chaudhary, A. (2015). Anti-
stress activity of A bioflavanoid: Quercetin from euphorbia 
hirta. British Journal of Pharmaceutical Research, 6(2), 68–75. 
[DOI:10.9734/BJPR/2015/16143]
Umukoro, S., & Aladeokin, A. C. (2010). Evaluation of the anti-
stress and anticonvulsant activities of leaf extract of Alchornea 
cordifolia in mice. Journal of Ethnopharmacology, 127(3), 768–70. 
[DOI:10.1016/j.jep.2009.11.023]
Walf, A. A., & Frye, C. A. (2007). The use of the elevated plus 
maze as an assay of anxiety-related behavior in rodents. Na-
ture Protocols, 2(2), 322–8. [DOI:10.1038/nprot.2007.44]
Toyin Olonode, E., et al. (2018). Morin Hydrate, Acute Stress-Induced Behavioral, and Biochemical Alterations. BCN, 9(2), 195-208.
Basic and Clinical
207
May, June 2018, Volume 9, Number 3
Wass, T. C., Scheithauer, B. W., Bronk, J. T., Wilson, R. M., & 
Lanier, W. L. (1996). Insulin treatment of corticosteroid-
associated hypergly-cemia and its effect on outcome af-
ter forebrain ischemia in rats. Anesthesiology, 84(3), 644–51. 
[DOI:10.1097/00000542-199603000-00020]
Watanabe, M., & Ayugase, J. (2008). Anti-stress effects of flavo-
noids from buckwheat sprouts in mice subjected to restraint 
Stress. Food Science and Technology Research, 14(3), 253–60. 
[DOI:10.3136/fstr.14.253]
Wijeratne, S. S. K., Abou Zaid, M. M., & Shahidi, F. (2006). An-
tioxidant polyphenols in almond and its coproducts. Journal 
of Agricultural and Food Chemistry, 54(2), 312–8. [DOI:10.1021/
jf051692j]
Wu, T. W., Fung, K. P., Yang, C. C., & D, R. (1995). Antioxida-
tion of human low density lipoprotein by horin hydrate. Life 
Sciences, 57(3), PL51–6. [DOI:10.1016/0024-3205(95)00274-A]
Wu, T. W., Zeng, L. H., Wu, J., & Fung, K. P. (1993). Morin 
hydrate is a plant-derived and antioxidant-based hepato-
protector. Life Sciences, 53(13), PL213–8. [DOI:10.1016/0024-
3205(93)90266-6]
Young, D. S., & Friedman, R. B. (2001). Effects of disease 
on clinical laboratory tests. Washington: AACC Press. 
[DOI:10.1086/321851] [PMID]
Zhang, R., Kang, K. A., Piao, M. J., Maeng, Y. H., Lee, K. H., 
Chang, W. Y., et al., (2009). Cellular protection of morin 
against the oxidative stress induced by hydrogen peroxide. 
Chemico-Biological Interactions, 177(1), 21–7. [DOI:10.1016/j.
cbi.2008.08.009]
Zhang, Z., Cao, X., Xiong, N., Wang, H., Huang, J., Sun, S., & 
Wang, T. (2010). Morin exerts neuroprotective actions in Par-
kinson disease models in vitro and in vivo. Acta Pharmacologi-
ca Sinica, 31(8), 900–6. [DOI:10.1038/aps.2010.77]
Toyin Olonode, E., et al. (2018). Morin Hydrate, Acute Stress-Induced Behavioral, and Biochemical Alterations. BCN, 9(2), 195-208.
Basic and Clinical
208
May, June 2018, Volume 9, Number 3
